The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A ...

UK surgeons remotely removed a man’s prostate cancer from 1,500 miles away in the country’s first successful robot-assisted telesurgery.

(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured a plenary prostate cancer session and a presentation by Dr. Henk van der Poel discussing the optimal management of ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

A surgeon in London has carried out what is being described as the United Kingdom’s first long-distance robotic operation on ...

A groundbreaking surgical procedure has demonstrated how robotics and ultra-low-latency networks could reshape the future of healthcare. A prostate cancer patient in Gibraltar successfully underwent ...

A cancer patient in Gibraltar was operated upon by an expert surgeon in London, 1,500 miles away, with the assistance of a robot specialised for the task, marking a major success for remote robotic ...

Bayer AG (BAYRY) announced an update on their ongoing clinical study. The CHINANEO trial is a Phase 2 Bayer study in China testing how well a combo of darolutamide and hormone therapy works before ...

A surgeon in London says he has performed the UK's first long‑distance robotic operation on a patient located 1,500 miles (2,400km) away in Gibraltar. Leading robotic urological surgeon Professor ...

On Wednesday, Prof Prokar Dasgupta, a leading robotic urological surgeon, performed a prostatectomy – a surgical removal of ...